Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management

Biochemical phenotyping has been the milestone for diagnosing and managing patients affected by inborn errors of intermediary metabolism (IEiM); however, identifying the genotype responsible for these monogenic disorders greatly contributes to achieving these goals. Herein, whole-exome sequencing (WES) was used to determine the genotypes of 95 unrelated Mexican pediatric patients suspected of having IEiM. They were classified into those bearing specific biochemical abnormalities (Group 1), and those presenting unspecific biochemical profiles (Group 2). The overall concordance between the initial biochemical diagnosis and final genotypic diagnoses was 72.6% (<i>N</i> = 69/95 patients), with the highest concordance achieved in Group 1 (91.3%, <i>N</i> = 63/69), whereas the concordance was limited in Group 2 (23.07%). This finding suggests that previous biochemical phenotyping correlated with the high WES diagnostic success. Concordance was high for urea cycle disorders (94.1%) and organic acid disorders (77.4%). The identified mutational spectrum comprised 83 IEiM-relevant variants (pathogenic, likely pathogenic, and variants of uncertain significance or VUS), including three novel ones, distributed among 29 different genes responsible for amino acid, organic acid, urea cycle, carbohydrate, and lipid disorders. Inconclusive WES results (7.3%, <i>N</i> = 7/95) relied on monoallelic pathogenic genotypes or those involving two VUS for autosomal-recessive IEiMs. A second monogenic disease was observed in 10.5% (<i>N</i> = 10/95) of the patients. According to the WES results, modifications in treatment had to be made in 33.6% (<i>N</i> = 32/95) of patients, mainly attributed to the presence of a second monogenic disease, or to an actionable trait. This study includes the largest cohort of Mexican patients to date with biochemically suspected IEiM who were genetically diagnosed through WES, underscoring its importance in medical management.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2024-10-31
DOI
https://doi.org/10.3390/ijms252111722
Citations
2
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.76
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management

Isabel Ibarra‐González, Hane Lee, Seung Woo Ryu, Sara Guillén‐López et al.
2 citations
International Journal of Molecular Sciences
Metabolism and Genetic Disorders
0.76
article

Concordance Between Biochemical and Molecular Diagnosis Obtained by WES in Mexican Patients with Inborn Errors of Intermediary Metabolism: Utility for Therapeutic Management

Isabel Ibarra‐González, Hane Lee, Seung Woo Ryu, Sara Guillén‐López, Cynthia Fernández‐Lainez, Miriam E. Reyna‐Fabián, Marcela Beatriz Vela-Amieva, Liliana Fernández‐Hernández, Leticia Belmont‐Martínez, Ariadna González‐del Angel, Bernardette Estandía‐Ortega, Lizbeth Alejandra López-Mejía, Miguel Angel Alcántara‐Ortigoza, Rosa Itzel Carrillo-Nieto
article en
2 citations

Abstract

Biochemical phenotyping has been the milestone for diagnosing and managing patients affected by inborn errors of intermediary metabolism (IEiM); however, identifying the genotype responsible for these monogenic disorders greatly contributes to achieving these goals. Herein, whole-exome sequencing (WES) was used to determine the genotypes of 95 unrelated Mexican pediatric patients suspected of having IEiM. They were classified into those bearing specific biochemical abnormalities (Group 1), and those presenting unspecific biochemical profiles (Group 2). The overall concordance between the initial biochemical diagnosis and final genotypic diagnoses was 72.6% (<i>N</i> = 69/95 patients), with the highest concordance achieved in Group 1 (91.3%, <i>N</i> = 63/69), whereas the concordance was limited in Group 2 (23.07%). This finding suggests that previous biochemical phenotyping correlated with the high WES diagnostic success. Concordance was high for urea cycle disorders (94.1%) and organic acid disorders (77.4%). The identified mutational spectrum comprised 83 IEiM-relevant variants (pathogenic, likely pathogenic, and variants of uncertain significance or VUS), including three novel ones, distributed among 29 different genes responsible for amino acid, organic acid, urea cycle, carbohydrate, and lipid disorders. Inconclusive WES results (7.3%, <i>N</i> = 7/95) relied on monoallelic pathogenic genotypes or those involving two VUS for autosomal-recessive IEiMs. A second monogenic disease was observed in 10.5% (<i>N</i> = 10/95) of the patients. According to the WES results, modifications in treatment had to be made in 33.6% (<i>N</i> = 32/95) of patients, mainly attributed to the presence of a second monogenic disease, or to an actionable trait. This study includes the largest cohort of Mexican patients to date with biochemically suspected IEiM who were genetically diagnosed through WES, underscoring its importance in medical management.

International Journal of Molecular SciencesVol. 25(21)
Secretaria de Salud (MX), Instituto Nacional de Pediatria (MX), HeidelbergCement (United States) (US)
Good health and well-being
Openalex Percentile: Top 26%
Metabolism and Genetic Disorders
0.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.